ESTRO 2024 - Abstract Book

S1423

Clinical - Head & neck

ESTRO 2024

outcome measurement, particularly in toxicity assessment tools utilised, time of toxicity assessment, method of delivery, and dose and fractionation delivered. The implementation of standardised outcome measures for future studies would increase uniformity in toxicity and clinical outcomes measurement methods.

Keywords: Oropharyngeal cancer, Toxicity, Radiation Therapy

References:

1. Dillon MT, Harrington KJ. Human Papillomavirus-Negative Pharyngeal Cancer. Journal of Clinical Oncology. 2015 Oct 10;33(29):3251-61.

2. Gillison ML, Chaturvedi AK, Anderson WF, Fakhry C. Epidemiology of Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma. Journal of Clinical Oncology. 2015 Oct 10;33(29):3235-42.

3. Rathod S, Gupta T, Ghosh-Laskar S, Murthy V, Budrukkar A, Agarwal J. Quality-oflife (QOL) outcomes in patients with head and neck squamous cell carcinoma (HNSCC) treated with intensity-modulated radiation therapy (IMRT) compared to three-dimensional conformal radiotherapy (3D-CRT): evidence from a prospective randomized study. Oral Oncology 2013 Jun;49(6):634-42. 4. Jeans EB, Shiraishi S, Manzar G, Morris LK, Amundson A, McGee LA, et al. A comparison of acute toxicities and patient ‐ reported outcomes between intensity ‐ modulated proton therapy and volumetric ‐ modulated arc therapy after ipsilateral radiation for head and neck cancers. Head & Neck. 2021 Dec 3;44(2):359 – 71. 5. Samuel SR, Maiya AG, Fernandes DJ, Guddattu V, Saxena PUP, Kurian JR, Lin PJ, Mustian KM. Effectiveness of exercise-based rehabilitation on functional capacity and quality of life in head and neck cancer patients receiving chemo-radiotherapy. Support Care Cancer. 2019 Oct;27(10):3913-3920. 6. Moreno AC, Frank SJ, Garden AS, Rosenthal DI, Fuller CD, Gunn GB, Reddy JP, Morrison WH, Williamson TD, Holliday EB, Phan J, Blanchard P. Intensity modulated proton therapy (IMPT) - The future of IMRT for head and neck cancer. Oral Oncol. 2019 Jan; 88:66-74. 7. Gunn GB, Blanchard P, Garden AS, Zhu XR, Fuller CD, Mohamed AS, Morrison WH, Phan J, Beadle BM, Skinner HD, Sturgis EM, Kies MS, Hutcheson KA, Rosenthal DI, Mohan R, Gillin MT, Frank SJ. Clinical Outcomes and Patterns of Disease Recurrence After Intensity Modulated Proton Therapy for Oropharyngeal Squamous Carcinoma. Int J Radiat Oncol Biol Phys. 2016 May 1;95(1):360-367.

8. Blanchard P, Gunn GB, Lin A, Foote RL, Lee NY, Frank SJ. Proton Therapy for Head and Neck Cancers. Semin Radiat Oncol. 2018 Jan;28(1):53-63.

9. Holliday EB, Kocak-Uzel E, Feng L, Thaker NG, Blanchard P, Rosenthal DI, Gunn GB, Garden AS, Frank SJ. Dosimetric advantages of intensity-modulated proton therapy for oropharyngeal cancer compared with intensity modulated radiation: A case-matched control analysis. Med Dosim. 2016 Autumn;41(3):189-94.